Ir al contenido principal
Volver a Discusiones

La industria biofarmacéutica y la sociedad

Healthcare
United States
Iniciada April 22, 2026

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality, and innovation. Drupal Admin Thu, 03/03/2016 - 15:36 Featured Image Image Contributors J. Stephen Morrison Downloads Download Transcript Here Document 160317_The_Bio-Pharma_Industry_and_Society_Tra...

Artículos de Fuentes

The Bio-Pharma Industry and Society

CSIS (United States) | Mar 03, 2016

Añadir afirmación Análisis 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 afirmaciones para votar • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 5/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Publicado por will • Apr 22, 2026
La industria biofarmacéutica debe priorizar la asequibilidad y el acceso para garantizar que los medicamentos que salvan vidas estén disponibles para todos, no solo para los ricos.
Traducido por IA · Ver original

The bio-pharma industry must prioritize affordability and access to ensure that life-saving medications are available to all, not just the wealthy.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Apr 22, 2026
Aunque la innovación es crucial, la búsqueda incesante de ganancias en el sector biofarmacéutico a menudo conduce a precios de medicamentos inflados, socavando la salud pública.
Traducido por IA · Ver original

While innovation is crucial, the relentless pursuit of profit in the bio-pharma sector often leads to inflated drug prices, undermining public health.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Apr 22, 2026
El enfoque en la innovación rápida en la industria biofarmacéutica puede comprometer la calidad y la seguridad de los medicamentos, generando riesgos para los pacientes.
Traducido por IA · Ver original

The focus on rapid innovation in the bio-pharma industry can compromise the quality and safety of medications, posing risks to patients.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Apr 22, 2026
Las asociaciones público-privadas en el sector biofarmacéutico pueden mejorar la investigación y el desarrollo, dando lugar a avances que benefician a la sociedad en su conjunto.
Traducido por IA · Ver original

Public-private partnerships in the bio-pharma sector can enhance research and development, leading to breakthroughs that benefit society as a whole.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results
CLAIM Publicado por will • Apr 22, 2026
Es necesario un enfoque equilibrado; la industria biofarmacéutica puede impulsar la innovación mientras aborda también cuestiones de acceso y asequibilidad.
Traducido por IA · Ver original

A balanced approach is necessary; the bio-pharma industry can drive innovation while also addressing issues of access and affordability.

Vote options for this statement: agree, disagree, or unsure
💬 Ver discusión
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us